Vista Pharmaceuticals
7.33
-0.20(-2.66%)
Market Cap₹45.07 Cr
PE Ratio-3.84
IndustryHealthcare
Company Performance:
1D-2.66%
1M-1.35%
6M-11.69%
1Y-38.14%
5Y-35.87%
View Company Insightsright
More news about Vista Pharmaceuticals
13Aug 25
Vista Pharmaceuticals Reports Widened Quarterly Loss, Reappoints Key Executives
Vista Pharmaceuticals Limited reported a net loss of Rs. 129.04 crore for Q1 FY2026, compared to Rs. 85.70 crore loss in Q1 FY2025. Revenue declined 15.4% to Rs. 151.88 crore. The company reappointed three key executives - Mr. Murali Meraga as Managing Director, Mr. Pavan Sathvik Gilaka and Mr. Dhananjaya Alli as Whole-time Directors for three-year terms. The 34th AGM is scheduled for September 30, 2025, via video conferencing. Book closure dates are set from September 24 to 30, 2025.
 no imag found
Vista Pharmaceuticals
7.33
-0.20
(-2.66%)
1 Year Returns:-38.14%
Industry Peers
Sun Pharmaceutical
1,779.00
(-0.55%)
Divis Laboratories
6,753.00
(+3.56%)
Torrent Pharmaceuticals
4,472.90
(+1.42%)
Zydus Life Science
1,105.60
(+1.66%)
Cipla
1,376.50
(-0.82%)
Dr Reddys Laboratories
1,268.50
(-0.56%)
Lupin
2,264.20
(+0.43%)
Mankind Pharma
2,391.00
(+1.43%)
Aurobindo Pharma
1,449.00
(-0.19%)
Laurus Labs
1,424.40
(+1.40%)